Radioligand fOr locAl raDiorecurrent proStaTe cancER

Clinical trial NCT05230251 · COMPLETED

Trial details

NCT number: NCT05230251
Sponsor: Glenn Bauman
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2022-03-17
Primary completion: 2023-09-25
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.